GoAI
Get started
Clarivate Plc logo

Clarivate Plc

CLVT

NYSETechnologyInformation Technology Services

Open in GoAI

Previous close

$2.08

+$0.01 · +0.48%

Aug 21, 4:00 PM ET

Pre-market

$2.04

−$0.04 · -1.92%

Aug 24, 4:00 AM ET

CLVT company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

45

Fair Value

Momentum

29

Weakening

Sentiment

66

Bullish

Risk resilience

31

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.

Industry
Information Technology Services
Sector
Technology
Headquarters
GB
CEO
Matitiahu Shem Tov
Listed since
Oct 29, 2018
Employees
12,000

Market position

Day range

Current $2.08

52-week range

Current $2.08

Open
$2.065
Previous close
$2.07
Volume
3.68M
0.59× average
Average volume
6.2M
Average daily volume
Market cap
1.33B USD
Beta
1.39
Market reference 1
50-day average
$2.1094
-1.39% below average
200-day average
$2.6323
-20.98% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
6.4B USD
P/E (TTM)
-4×
P/B (TTM)
0.29×
P/S (TTM)
0.55×
EV / EBITDA
6.89×
Earnings yield
-8.94%
Free cash flow yield
16.24%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
66.82%
Operating margin
-3.51%
Net margin
-13.84%
Return on equity
-4.15%
Return on assets
-1.82%
Return on invested capital
0.74%

Financial health

Debt / equity
0.94×
Current ratio
0.84×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends88%2%-84%-170%Gross margin, FY2021: 66.64%Gross margin, FY2022: 64.13%Gross margin, FY2023: 65.52%Gross margin, FY2024: 66.00%Gross margin, FY2025: 66.05%Operating margin, FY2021: -4.64%Operating margin, FY2022: -147.59%Operating margin, FY2023: -27.95%Operating margin, FY2024: -10.78%Operating margin, FY2025: 2.91%Net margin, FY2021: -14.41%Net margin, FY2022: -148.89%Net margin, FY2023: -34.66%Net margin, FY2024: -24.90%Net margin, FY2025: -8.19%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 66.64%. Gross margin FY2022 64.13%. Gross margin FY2023 65.52%. Gross margin FY2024 66.00%. Gross margin FY2025 66.05%. Operating margin FY2021 -4.64%. Operating margin FY2022 -147.59%. Operating margin FY2023 -27.95%. Operating margin FY2024 -10.78%. Operating margin FY2025 2.91%. Net margin FY2021 -14.41%. Net margin FY2022 -148.89%. Net margin FY2023 -34.66%. Net margin FY2024 -24.90%. Net margin FY2025 -8.19%.

Income trends

Revenue

2.46B USD-3.97%

Operating income

71.5M USD+347.1M USD

Net income

−201.1M USD+68.42%
Income trends across reported periods3.32B USD673.8M USD−1.97B USD−4.62B USDRevenue, FY2021: 1.88B USDRevenue, FY2022: 2.66B USDRevenue, FY2023: 2.63B USDRevenue, FY2024: 2.56B USDRevenue, FY2025: 2.46B USDOperating income, FY2021: −87M USDOperating income, FY2022: −3.93B USDOperating income, FY2023: −734.7M USDOperating income, FY2024: −275.6M USDOperating income, FY2025: 71.5M USDNet income, FY2021: −270.5M USDNet income, FY2022: −3.96B USDNet income, FY2023: −911.2M USDNet income, FY2024: −636.7M USDNet income, FY2025: −201.1M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.88B USD. Revenue FY2022 2.66B USD. Revenue FY2023 2.63B USD. Revenue FY2024 2.56B USD. Revenue FY2025 2.46B USD. Operating income FY2021 −87M USD. Operating income FY2022 −3.93B USD. Operating income FY2023 −734.7M USD. Operating income FY2024 −275.6M USD. Operating income FY2025 71.5M USD. Net income FY2021 −270.5M USD. Net income FY2022 −3.96B USD. Net income FY2023 −911.2M USD. Net income FY2024 −636.7M USD. Net income FY2025 −201.1M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue2.46B USD2.56B USD2.63B USD2.66B USD1.88B USD
Cost of goods sold833.6M USD869.2M USD906.4M USD954M USD626.1M USD
Gross profit1.62B USD1.69B USD1.72B USD1.71B USD1.25B USD
Selling, general, and administrative708.6M USD727.6M USD739.7M USD729.9M USD643M USD
Operating expenses1.55B USD1.96B USD2.46B USD5.63B USD1.34B USD
Interest expense265.4M USD283.4M USD293.7M USD270.3M USD252.5M USD
Depreciation and amortization757.2M USD727M USD708.3M USD710.5M USD537.8M USD
Operating income71.5M USD−275.6M USD−734.7M USD−3.93B USD−87M USD
Net income−201.1M USD−636.7M USD−911.2M USD−3.96B USD−270.5M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
73%
8 beats, 0 misses, 3 met estimates
Average EPS surprise
+10.27%
11 comparable reports
Latest EPS result
0.19
Estimate 0.18 · Beat by 4.63%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.250.20.150.1Q1 '25BeatQ2 '25BeatQ3 '25MetQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 19, 2025: actual 0.21, estimate 0.2, surprise +5.00%, Beat. Q2 2025, reported Apr 29, 2025: actual 0.14, estimate 0.12, surprise +16.67%, Beat. Q3 2025, reported Jul 30, 2025: actual 0.18, estimate 0.18, surprise 0.00%, Met estimate. Q4 2025, reported Oct 29, 2025: actual 0.18, estimate 0.16, surprise +12.50%, Beat. Q1 2026, reported Feb 24, 2026: actual 0.2, estimate 0.16, surprise +25.00%, Beat. Q2 2026, reported Apr 29, 2026: actual 0.18, estimate 0.14, surprise +28.57%, Beat. Q3 2026, reported Jul 29, 2026: actual 0.19, estimate 0.182, surprise +4.63%, Beat. Q4 2026, reported Nov 4, 2026: actual —, estimate 0.19, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates689.52M639.76M590.01M540.25MQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 19, 2025: actual 663M USD, estimate 601.15M USD, surprise +10.29%, Beat. Q2 2025, reported Apr 29, 2025: actual 593.7M USD, estimate 587.46M USD, surprise +1.06%, Beat. Q3 2025, reported Jul 30, 2025: actual 621.4M USD, estimate 570.35M USD, surprise +8.95%, Beat. Q4 2025, reported Oct 29, 2025: actual 623.1M USD, estimate 604.79M USD, surprise +3.03%, Beat. Q1 2026, reported Feb 24, 2026: actual 617M USD, estimate 604.79M USD, surprise +2.02%, Beat. Q2 2026, reported Apr 29, 2026: actual 585.5M USD, estimate 569.5M USD, surprise +2.81%, Beat. Q3 2026, reported Jul 29, 2026: actual 587.3M USD, estimate 589.73M USD, surprise -0.41%, Miss. Q4 2026, reported Nov 4, 2026: actual —, estimate 566.77M USD, surprise —, Comparison unavailable.

CLVT news

fool.com

Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?

Cornick's purchase increased his total holdings by 74% despite stock declining 52% over the past year, signaling conviction in the company's recovery prospects.

Read source
prnewswire.com

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

Expanded capabilities across Cortellis portfolio help life sciences organizations turn trusted intelligence into action and accelerate decision making across the research and development lifecycle LONDON, Aug. 6, 2026…

Read source
defenseworld.net

First Trust Advisors LP Has $13.97 Million Stock Holdings in Clarivate PLC $CLVT

First Trust Advisors LP lifted its stake in shares of Clarivate PLC (NYSE: CLVT) by 10.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund…

Read source
marketbeat.com

Clarivate Q2 Earnings Call Highlights

Clarivate NYSE: CLVT said during its earnings call that it expects organic recurring revenue and annualized contract value growth to improve in the second half of the year, citing renewal visibility, product momentum and…

Read source
seekingalpha.com

Clarivate Plc (CLVT) Q2 2026 Earnings Call Transcript

Clarivate Plc (CLVT) Q2 2026 Earnings Call Transcript

Read source
zacks.com

Clarivate (CLVT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Clarivate (CLVT) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago…

Read source

CLVT peers

Taiwan Semiconductor Manufacturing Company Limited logo

TSM

Taiwan Semiconductor Manufacturing Company Limited

$418.95

+0.71%

Oracle Corporation logo

ORCL

Oracle Corporation

$146.47

+3.10%

Dell Technologies Inc. logo

DELL

Dell Technologies Inc.

$441.98

+1.66%

SAP SE logo

SAP

SAP SE

$218.68

+0.73%

Arista Networks, Inc. logo

ANET

Arista Networks, Inc.

$188.65

+2.67%

International Business Machines Corporation logo

IBM

International Business Machines Corporation

$235.68

+0.85%

ETFs holding CLVT

Funds reporting this stock among their holdings, ordered by reported position size.

Avantis U.S. Small Cap Value ETF logoAvantis U.S. Small Cap Value ETFAVUV
Market value
30.32M
Weight
0.10%
AUM
31.27B USD
Expense ratio
0.25%
Price / 1D
$126.45+0.66%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
18.34M
Weight
0.02%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
9.77M
Weight
0.01%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
iShares Russell 2000 Value ETF logoiShares Russell 2000 Value ETFIWN
Market value
6.9M
Weight
0.05%
AUM
14.66B USD
Expense ratio
0.24%
Price / 1D
$224.81+0.45%
Dimensional - US Small Cap Value ETF logoDimensional - US Small Cap Value ETFDFSV
Market value
5.2M
Weight
0.06%
AUM
8.42B USD
Expense ratio
0.30%
Price / 1D
$40.29+0.72%
Schwab Fundamental U.S. Small Company Index ETF logoSchwab Fundamental U.S. Small Company Index ETFFNDA
Market value
4.97M
Weight
0.05%
AUM
9.26B USD
Expense ratio
0.25%
Price / 1D
$37.73+0.75%
EA Bridgeway Omni Small-Cap Value ETF logoEA Bridgeway Omni Small-Cap Value ETFBSVO
Market value
4.65M
Weight
0.19%
AUM
1.71B USD
Expense ratio
0.47%
Price / 1D
$29.62+0.85%
Schwab U.S. Small-Cap ETF logoSchwab U.S. Small-Cap ETFSCHA
Market value
4.2M
Weight
0.02%
AUM
23.1B USD
Expense ratio
0.03%
Price / 1D
$34.83+0.52%

Continue in GoAI

Research CLVT

research.disclaimer